Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / COM
-
Number of holders
-
173
-
Total 13F shares, excl. options
-
43,663,491
-
Shares change
-
+731,604
-
Total reported value, excl. options
-
$2,949,433,796
-
Value change
-
+$53,650,639
-
Put/Call ratio
-
63%
-
Number of buys
-
95
-
Number of sells
-
-71
-
Price
-
$67.55
Significant Holders of AERIE PHARMACEUTICALS INC - COM (AERI) as of Q2 2018
206 filings reported holding AERI - AERIE PHARMACEUTICALS INC - COM as of Q2 2018.
AERIE PHARMACEUTICALS INC - COM (AERI) has 173 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 43,663,491 shares
.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (5,325,289 shares), VANGUARD GROUP INC (3,450,616 shares), BlackRock Inc. (2,991,101 shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (2,800,000 shares), Partner Fund Management, L.P. (2,720,218 shares), ORBIMED ADVISORS LLC (1,884,100 shares), Foresite Capital Management III, LLC (1,708,046 shares), Foresite Capital Management II, LLC (1,464,749 shares), HealthCor Management, L.P. (1,314,290 shares), and JENNISON ASSOCIATES LLC (1,309,821 shares).
This table shows the top 173 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.